RECRUITINGOBSERVATIONAL
A Study of Olanzapine in Participants With Bipolar Disorder.
A Multicenter, Prospective Observational Study to Evaluate Treatment Patterns and Safety in Patients With Bipolar Disorder Taking Olanzapine
About This Trial
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients who have signed the willing to sign a consent form after receiving information about the purpose and method of this study.
- Patients diagnosed with bipolar disorder and scheduled to receive olanzapine.
- Patients who understand the contents of the survey and can answer the questions directly.
Who Should NOT Join This Trial:
- Female patients who are pregnant, have childbearing potential, or are breastfeeding.
- Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
- Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients who have signed the informed consent after receiving information about the purpose and method of this study.
* Patients diagnosed with bipolar disorder and scheduled to receive olanzapine.
* Patients who understand the contents of the survey and can answer the questions directly.
Exclusion Criteria:
* Female patients who are pregnant, have childbearing potential, or are breastfeeding.
* Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
* Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.
Treatments Being Tested
DRUG
Olanzapine
As this is a non-interventional study designed to collect data as part of routine clinical practice, the selection and dosage of medication, treatment period, and whether or not to change it are all based on the clinician's judgment.
Locations (1)
CHA Bundang Medical Center
Seongnam, South Korea